Literature DB >> 26015476

Neutrophils play an important role in protective immunity against Coxiella burnetii infection.

Alexandra Elliott1, Laura Schoenlaub1, Danielle Freches1, William Mitchell1, Guoquan Zhang2.   

Abstract

Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes the zoonotic disease Q fever. Although Q fever is mainly transmitted by aerosol infection, study of the immune responses in the lung following pulmonary C. burnetii infection is lacking. Neutrophils are considered the first immune cell to migrate into the lung and play an important role in host defense against aerosol infection with microbial pathogens. However, the role of neutrophils in the host defense against C. burnetii infection remains unclear. To determine the role of neutrophils in protective immunity against C. burnetii infection, the RB6-8C5 antibody was used to deplete neutrophils in mice before intranasal infection with C. burnetii. The results indicated that neutrophil-depleted mice developed more severe disease than their wild-type counterparts, suggesting that neutrophils play an important role in host defense against C. burnetii pulmonary infection. We also found that neither CXC chemokine receptor 2 (CXCR2) nor interleukin-17 (IL-17) receptor (IL-17R) deficiency changed the severity of disease following intranasal C. burnetii challenge, suggesting that keratinocyte-derived chemokine and IL-17 may not play essential roles in the response to C. burnetii infection. However, significantly higher C. burnetii genome copy numbers were detected in the lungs of IL-1R(-/-) mice at 14 days postinfection. This indicates that IL-1 may be important for the clearance of C. burnetii from the lungs following intranasal infection. Our results also suggest that neutrophils are involved in protecting vaccinated mice from C. burnetii challenge-induced disease. This is the first study to demonstrate an important role for neutrophils in protective immunity against C. burnetii infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26015476      PMCID: PMC4496591          DOI: 10.1128/IAI.00042-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Airborne Q fever.

Authors:  W D TIGERTT; A S BENENSON; W S GOCHENOUR
Journal:  Bacteriol Rev       Date:  1961-09

2.  Laboratory maintenance of Coxiella burnetii.

Authors:  James E Samuel; Laura R Hendrix
Journal:  Curr Protoc Microbiol       Date:  2009-11

3.  Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.

Authors:  Wiebke Herbold; Regina Maus; Ines Hahn; Nadine Ding; Mrigank Srivastava; John W Christman; Matthias Mack; Jörg Reutershan; David E Briles; James C Paton; Christine Winter; Tobias Welte; Ulrich A Maus
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

4.  The importance of neutrophils in resistance to pneumococcal pneumonia in adult and neonatal mice.

Authors:  B A Garvy; A G Harmsen
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

5.  Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice.

Authors:  J C Williams; J L Cantrell
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice.

Authors:  J C Williams; T A Damrow; D M Waag; K Amano
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

8.  Inhibition of the human neutrophil NADPH oxidase by Coxiella burnetii.

Authors:  Daniel W Siemsen; Liliya N Kirpotina; Mark A Jutila; Mark T Quinn
Journal:  Microbes Infect       Date:  2009-04-18       Impact factor: 2.700

9.  The isolation and characterization of murine macrophages.

Authors:  Xia Zhang; Ricardo Goncalves; David M Mosser
Journal:  Curr Protoc Immunol       Date:  2008-11

10.  Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.

Authors:  Samithamby Jeyaseelan; Scott K Young; Masahiro Yamamoto; Patrick G Arndt; Shizuo Akira; Jay K Kolls; G Scott Worthen
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.426

View more
  10 in total

1.  Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1.

Authors:  Rama Cherla; Yan Zhang; Lindsey Ledbetter; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

2.  Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.

Authors:  Laura Buttrum; Lindsey Ledbetter; Rama Cherla; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.

Authors:  Lindsey Ledbetter; Rama Cherla; Catherine Chambers; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

4.  Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.

Authors:  Tatiana M Clemente; Minal Mulye; Anna V Justis; Srinivas Nallandhighal; Tuan M Tran; Stacey D Gilk
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

Review 5.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 6.  Farming, Q fever and public health: agricultural practices and beyond.

Authors:  Marcella Mori; Hendrik-Jan Roest
Journal:  Arch Public Health       Date:  2018-01-06

7.  Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.

Authors:  Jemma O'Connor; Michael J Vjecha; Andrew N Phillips; Brian Angus; David Cooper; Beatriz Grinsztejn; Gustavo Lopardo; Satyajit Das; Robin Wood; Aimee Wilkin; Hartwig Klinker; Pacharee Kantipong; Karin L Klingman; David Jilich; Elbushra Herieka; Eileen Denning; Ibrahim Abubakar; Fred Gordin; Jens D Lundgren
Journal:  Lancet HIV       Date:  2017-01-05       Impact factor: 12.767

8.  Permissiveness of bovine epithelial cells from lung, intestine, placenta and udder for infection with Coxiella burnetii.

Authors:  Katharina Sobotta; Katharina Bonkowski; Elisabeth Liebler-Tenorio; Pierre Germon; Pascal Rainard; Nina Hambruch; Christiane Pfarrer; Ilse D Jacobsen; Christian Menge
Journal:  Vet Res       Date:  2017-04-12       Impact factor: 3.683

9.  MyD88 Is Required for Efficient Control of Coxiella burnetii Infection and Dissemination.

Authors:  Lisa Kohl; Inaya Hayek; Christoph Daniel; Jan Schulze-Lührmann; Barbara Bodendorfer; Anja Lührmann; Roland Lang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

10.  Expression of human TLR4/myeloid differentiation factor 2 directs an early innate immune response associated with modest increases in bacterial burden during Coxiella burnetii infection.

Authors:  Amanda Robison; Deann T Snyder; Kelly Christensen; Emily Kimmel; Adeline M Hajjar; Mark A Jutila; Jodi F Hedges
Journal:  Innate Immun       Date:  2019-06-10       Impact factor: 2.680

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.